Insider filing · MRVI

Bernd Brust bought $703K of Maravai Lifesciences (MRVI)

Executed Nov 13 2025, disclosed Nov 17 2025, 4 days later.

Over the 21 trading sessions from the disclosed entry session (Nov 17 2025), the stock returned +0.0% (delay-adjusted); from the execution session (Nov 13 2025), +11.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

BB Bernd Brust Chief Executive Officer profile →

Bernd Brust (Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in MRVI. Across 2 priced purchase filings, the average 21-session return was +15.9% from execution and +5.9% from disclosure (delay-adjusted; derived). The largest single filing was $809K of MRVI (250,559 sh across 2 lots, as filed), executed Nov 11 2025.

MRVI MRVI MRVI · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→